Home › Therapeutic areas › Cardiovascular › Paroxysmal Supraventricular Tachycardia

Paroxysmal Supraventricular Tachycardia (1 companies)

Companies with an active program in Paroxysmal Supraventricular Tachycardia.

Ticker Company Therapeutic areas Programs Lead stage Mkt cap Programs
MIST Milestone Pharmaceuticals Cardiovascular 1 Approved $95.0M 2